From: Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden
BC only patients (no. of SNPs) | Gene (known breast cancer gene) | SNP | Effect of mutation *- potential **- known association |
---|---|---|---|
T-1 (3) | ATM | c.8965C > G | p.Gln2989Glu* |
MUTYH | c.1435G > A | p.Glu479Lys* | |
FANCB | c.2435A > G | p.Tyr812Cys* | |
T-2 (2) | MSR1 | c.919G > T | p.Asp307Tyr* |
ATM | c.6067G > A | p.Gly2023Arg | |
T-3 (4) | RAD50 | c.1741C > T | p.His581Tyr* |
MITF | c.1255G > T | p.Glu419Ter** | |
WRN | c.95A > G | p.Lys32Arg | |
APC | c.7490C > T | p.Ser2497Leu | |
T-4 (6) | ELANE | c.341 T > C | p.Leu114Ser* |
RB1 | c.10A > C | p.Lys4Gln* | |
WRN | c.1149G > T | p.Leu383Phe | |
ERCC4 | c.1135C > T | p.Pro379Ser | |
MSR1 | c.667 T > A | p.Ser223Thr* | |
WRN | c.2983G > A | p.Ala995Thr | |
T-5 (1) | TSC1 | c.1390G > A | p.Gly464Ser* |
T-6 (1) | CHEK2 | c.190G > A | p.Glu64Lys** |
T-7 (3) | MSH2 | c.2187G > A | p.Met729Ile* |
RAD50 | c.734A > G | p.Glu245Gly* | |
FANCA | c.2658G > C | p.Glu886Asp* | |
T-8 (2) | CDH1 | c.344C > T | p.Thr115Met* |
MET | c.2962C > T | p.Arg988Cys | |
T-9 (6) | MDH2 | c.415G > A | p.Val139Ile* |
FANCA | c.1874G > C | p.Cys625Ser | |
ATR | c.7303A > G | p.Ile2435Val* | |
TERT | c.2726 T > C | p.Val909Ala* | |
PALB2 | c.2483G > A | p.Cys828Tyr* | |
FANCB | c.454 T > C | p.Phe152Leu* | |
T-10 (3) | RECQL4 | c.616A > C | p.Lys206Gln* |
BLM | c.3536C > T | p.Thr1179Ile* | |
FANCC | c.632C > G | p.Pro211Arg | |
T-11 (3) | MITF | c.1334C > A | p.Thr445Lys |
WRN | c.1211 T > C | p.Ile404Thr | |
SLX4 | c.179A > C | p.Gln60Pro | |
T-12 (1) | FANCI | c.824 T > C | p.Ile275Thr |
T-13 (3) | BUB1 | c.307A > G | p.Ile103Val |
FANCA | c.1874G > C | p.Cys625Ser | |
AXIN2 | c.1994delG | p.Gly665fs* | |
T-14 (3) | RECQL4 | c.941C > T | p.Pro314Leu |
SLX4 | c.4963A > G | p.Arg1655Gly | |
RAD51C | c.130 T > C | p.Ser44Pro | |
T-15 (1) | PMS1 | c.1609G > A | p.Glu537Lys* |